TET2 and T-cell leukemia: Besides, Tet2 downregulation was vital for 5-hydroxymethylcytocine (5hmC) regulation in adult T-cell leukemia/lymphoma (ATLL) progression [20] and Tet2-KO mice developed myeloid cancers with an incidence rate of about 30% [21].